The concomitant usage of oxycodone HCl with all cytochrome P450 3A4 inhibitors may bring about an increase in oxycodone plasma concentrations, which could enhance or prolong adverse reactions and should cause potentially deadly respiratory melancholy. On top of that, discontinuation of the concomitantly used cytochrome P450 3A4 inducer could cause